wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37827875-3475C12F-5582-4357-A894-67961D8DDDE6
Q37827875-3475C12F-5582-4357-A894-67961D8DDDE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37827875-3475C12F-5582-4357-A894-67961D8DDDE6
Treatment of chronic myeloid leukemia when imatinib fails.
P2860
Q37827875-3475C12F-5582-4357-A894-67961D8DDDE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37827875-3475C12F-5582-4357-A894-67961D8DDDE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bdc5eb7791280559a0d89eeb4e3f7417a9f46789
P2860
Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily.